CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Josef Ehling(RWTH Aachen University), Frank Tacke(Charité - Universitätsmedizin Berlin), Christer Baeck(Universitätsklinikum Aachen), Fabian Kießling(Universitätsklinikum Aachen), Dirk Eulberg(Noxxon Pharma (Germany)), Matthias Bartneck(DWI – Leibniz Institute for Interactive Materials), Felix Gremse(RWTH Aachen University), Viktor Fech(Universitätsklinikum Aachen), Twan Lammers(RWTH Aachen University), Kanishka Hittatiya(University of Bonn), Xiao Wei(Universitätsklinikum Aachen), Tom Luedde(Düsseldorf University Hospital), Diana Möckel(RWTH Aachen University), Christian Trautwein(TUM Klinikum)
Cited by 269
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k